These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28351203)

  • 1. Effects of varenicline on alcohol self-administration and craving in drinkers with depressive symptoms.
    Roberts W; Verplaetse TL; Moore K; Oberleitner L; Picciotto MR; McKee SA
    J Psychopharmacol; 2017 Jul; 31(7):906-914. PubMed ID: 28351203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Varenicline Alone and in Combination With Low-dose Naltrexone on Alcohol-primed Smoking in Heavy-drinking Tobacco Users: A Preliminary Laboratory Study.
    Roberts W; Shi JM; Tetrault JM; McKee SA
    J Addict Med; 2018; 12(3):227-233. PubMed ID: 29438157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of varenicline on cognitive performance in heavy drinkers: Dose-response effects and associations with drinking outcomes.
    Roberts W; McKee SA
    Exp Clin Psychopharmacol; 2018 Feb; 26(1):49-57. PubMed ID: 29389170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of varenicline on alcohol cue reactivity in heavy drinkers.
    Roberts W; Harrison ELR; McKee SA
    Psychopharmacology (Berl); 2017 Sep; 234(18):2737-2745. PubMed ID: 28600734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Lowering the Dose of Varenicline on Alcohol Self-administration in Drinkers With Alcohol Use Disorders.
    Verplaetse TL; Pittman BP; Shi JM; Tetrault JM; Coppola S; McKee SA
    J Addict Med; 2016; 10(3):166-73. PubMed ID: 27159341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distress Tolerance and Craving for Cigarettes Among Heavy Drinking Smokers.
    Lim AC; Roche DJO; Ray LA
    J Stud Alcohol Drugs; 2018 Nov; 79(6):918-928. PubMed ID: 30573023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings.
    Ray LA; Courtney KE; Ghahremani DG; Miotto K; Brody A; London ED
    Psychopharmacology (Berl); 2014 Oct; 231(19):3843-53. PubMed ID: 24733235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism.
    Froehlich JC; Fischer SM; Dilley JE; Nicholson ER; Smith TN; Filosa NJ; Rademacher LC
    Alcohol Clin Exp Res; 2016 Sep; 40(9):1961-70. PubMed ID: 27469281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individuals.
    Schacht JP; Anton RF; Randall PK; Li X; Henderson S; Myrick H
    Psychopharmacology (Berl); 2014 Sep; 231(18):3799-807. PubMed ID: 24647921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Varenicline on Alcohol Consumption in Subjects With Alcohol Use Disorders: Systematic Review and Meta-Analyses.
    Gandhi KD; Mansukhani MP; Karpyak VM; Schneekloth TD; Wang Z; Kolla BP
    J Clin Psychiatry; 2020 Feb; 81(2):. PubMed ID: 32097546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderators of Varenicline Treatment Effects in a Double-Blind, Placebo-Controlled Trial for Alcohol Dependence: An Exploratory Analysis.
    Falk DE; Castle IJ; Ryan M; Fertig J; Litten RZ
    J Addict Med; 2015; 9(4):296-303. PubMed ID: 26083958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Varenicline on Neural Correlates of Alcohol Salience in Heavy Drinkers.
    Vatsalya V; Gowin JL; Schwandt ML; Momenan R; Coe MA; Cooke ME; Hommer DW; Bartlett S; Heilig M; Ramchandani VA
    Int J Neuropsychopharmacol; 2015 Jul; 18(12):. PubMed ID: 26209857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment-Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline.
    Miranda R; O'Malley SS; Treloar Padovano H; Wu R; Falk DE; Ryan ML; Fertig JB; Chun TH; Muvvala SB; Litten RZ
    Alcohol Clin Exp Res; 2020 Jul; 44(7):1431-1443. PubMed ID: 32363592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements.
    Childs E; Roche DJ; King AC; de Wit H
    Alcohol Clin Exp Res; 2012 May; 36(5):906-14. PubMed ID: 22339626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varenicline for treatment of alcohol dependence: a randomized, placebo-controlled trial.
    de Bejczy A; Löf E; Walther L; Guterstam J; Hammarberg A; Asanovska G; Franck J; Isaksson A; Söderpalm B
    Alcohol Clin Exp Res; 2015 Nov; 39(11):2189-99. PubMed ID: 26414337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Varenicline on the Neural Processing of Fearful Faces and the Subjective Effects of Alcohol in Heavy Drinkers.
    Gowin JL; Vatsalya V; Westman JG; Schwandt ML; Bartlett S; Heilig M; Momenan R; Ramchandani VA
    Alcohol Clin Exp Res; 2016 May; 40(5):979-87. PubMed ID: 27062270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels.
    Nieto SJ; Enders CK; Witkiewitz K; O'Malley SS; Ray LA
    Alcohol Clin Exp Res; 2022 Dec; 46(12):2258-2266. PubMed ID: 36515648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Combination of Naltrexone + Varenicline Retards the Expression of a Genetic Predisposition Toward High Alcohol Drinking.
    Froehlich JC; Fischer SM; Nicholson ER; Dilley JE; Filosa NJ; Smith TN; Rademacher LC
    Alcohol Clin Exp Res; 2017 Mar; 41(3):644-652. PubMed ID: 28055135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderation of Prazosin's Efficacy by Alcohol Withdrawal Symptoms.
    Sinha R; Wemm S; Fogelman N; Milivojevic V; Morgan PM; Angarita GA; Hermes G; Fox HC
    Am J Psychiatry; 2021 May; 178(5):447-458. PubMed ID: 33207935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol use disorder severity moderates clinical response to varenicline.
    Donato S; Green R; Ray LA
    Alcohol Clin Exp Res; 2021 Sep; 45(9):1877-1887. PubMed ID: 34486130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.